| MR编号 | DE/V/0022/001 |
|---|
| 药品名称 | Rispoval IBR-Marker vivum |
|---|
| 活性成分 | - bovine herpesvirus lyophylisated 2.0 ml
|
|---|
| 剂型 | Powder and solvent for solution for injection |
|---|
| 上市许可持有人 | Zoetis Deutschland GmbH
Schellingstr. 1
10785 Berlin |
|---|
| 参考成员国 - 产品名称 | Germany (DE) |
|---|
| 互认成员国 - 产品名称 | - Belgium (BE)
Rispoval IBR-Marker vivum - Netherlands (NL)
- Luxembourg (LU)
- Ireland (IE)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Poland (PL)
- Latvia (LV)
Rispoval IBR-Marker Inactivatum - Lithuania (LT)
Rispoval IBR-Marker Inactivatum, injekcinė suspensija galvijams - Estonia (EE)
- Hungary (HU)
- Bulgaria (BG)
Rispoval IBR-Marker Vivum - Czechia (CZ)
- Romania (RO)
- Slovakia (SK)
- Slovenia (SI)
- United Kingdom (Northern Ireland) (XI)
|
|---|
| 许可日期 | 2008/04/05 |
|---|
| 最近更新日期 | 2024/09/24 |
|---|
| 药物ATC编码 | - QI02AD Live viral vaccines
- QI02 IMMUNOLOGICALS FOR BOVIDAE
- QI02A CATTLE
- QI02AD01 bovine rhinotracheitis virus (IBR)
- QI IMMUNOLOGICALS
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：Full Dossier (art.5)
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|